|
Avoiding More Regulatory Oversight in OTC Derivatives: The Best Defense Is a Good OffenseProduct Type: Market Research ReportPublished by: TowerGroup Published: May 2008 Product Code: R301-1462 Description The current method for processing over-the-counter (OTC) derivatives remains opaque and involves too much paper and to many manual processes. To address the limitations, on March 27, 2008, the Operations Management Group sent a letter to the New York Federal Reserve Bank detailing self-imposed improvements to the processing of these complex instruments. Their commitments will change the processing of OTC derivatives and affect the technology providers, the sell side, the buy side, and custodians. This TowerGroup ViewPoint explores the stakeholders' commitments and discusses the impact on organizations that participate in the OTC derivatives market.
Table of Contents
|
|
||||||||
MindBranch has been the leading provider of industry and investment research from more than 550 independent research firms since 1992. With over 90,000 market research reports, MindBranch is your trusted source of competitive business intelligence. |